Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Incidence and Significance of EEG Abnormalities in Atraumatic Convexity Subarachnoid Hemorrhage
Cerebrovascular Disease and Interventional Neurology
P13 - Poster Session 13 (5:30 PM-6:30 PM)
4-005

To identify the incidence and clinical significance of electroencephalogram (EEG) abnormalities in patients with atraumatic convexity subarachnoid hemorrhage (cSAH).  



Atraumatic cSAH presents with seizures in 6-30% of cases. Seizures are commonly reported in cerebral venous sinus thrombosis (cVST), occasionally in cerebral amyloid angiopathy (CAA), and less commonly in reversible cerebral vasoconstriction syndrome (RCVS).  EEG is often employed in the workup, but it is unclear to what degree abnormalities can be attributed to cortical injury versus epileptogenic focus. 



We retrospectively studied clinical, EEG, and imaging data of patients with acute cSAH who underwent EEG.  EEG was interpreted by a board-certified epileptologist. 



Of 26 patients with cSAH undergoing EEG, 6 presented with seizure, 9 presented with encephalopathy, 11 presented with focal neurologic deficit, and 3 presented with headache.  CAA was the most common etiology and the most common location of cSAH was frontal. 5 patients had a history of epilepsy.  The majority of EEGs were abnormal, with only 3 patients having a normal EEG.  In 8 patients, a clinical event was captured.  Abnormalities included focal slowing (14), generalized slowing (10), and epileptiform discharges (7).  18 patients had a seizure at any point from presentation to follow-up visit; 4 had status epilepticus. Most patients (20) were discharged on an anti epileptic drug (AED), with 6 patients discharged on multiple AEDs.  At follow-up, 14 patients remained on AED. 



In patients with cSAH suspected of seizure, EEG has a high yield in capturing abnormalities and clinical events.  The majority of patients undergoing EEG sustained a seizure at some point during or after hospitalization; however, there is considerable selection bias given that not all cSAH patients underwent EEG. Further prospective studies inclusive of all patients with cSAH regardless of clinical suspicion, are needed to elucidate the true incidence of EEG abnormalities in this condition. 

Authors/Disclosures
Katarina B. Dakay, DO
PRESENTER
No disclosure on file
Jacob Didion, MD No disclosure on file
Lisa Knopf, MD (Hartford Healthcare) No disclosure on file
Ali Mahta, MD (Brown University) Dr. Mahta has received research support from Brown University Health.
Shadi Yaghi, MD (Hackensack Meridian Health) Dr. Yaghi has nothing to disclose.
Shawna M. Cutting, MD, FÂé¶¹´«Ã½Ó³»­ The institution of Dr. Cutting has received research support from Genentech.